Similar companies
Income Statement (USD)
Q2 '24 | QoQ | |
---|---|---|
Revenue | 112M | 4.5% |
Gross Profit | 38M | 4.9% |
Cost of Revenue | 39M | 0.8% |
Operating expense | 24M | 2.8% |
Net Income | 12M | 19.6% |
EBITDA | 16M | 18.8% |
Balance Sheet (USD)
Q2 '24 | QoQ | |
---|---|---|
Total Assets | 363M | 2.6% |
Total Liabilities | 44M | 4.2% |
Total Equity | 320M | 3.6% |
Shares Outstanding | 22M | 0.4% |
Cash Flow (USD)
Q2 '24 | QoQ | |
---|---|---|
Cash from operations | 9.6M | 89.8% |
Cash from investing | -11M | 366% |
Cash from financing | -2.9M | 7459% |
EPS
Financial Highlights for LeMaitre Vascular in Q2 '24
LeMaitre Vascular reported a revenue of 112M, which is a 4.5% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 38M, marking a 4.9% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 39M, a -0.8% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 24M, showing a -2.8% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was 12M, showing a 19.6% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was 16M, showing a 18.8% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
It was a positive quarter for LeMaitre Vascular with growth in revenue, gross profit, and net income.